2-Methyl-AP-237: Research Chemistry, Pharmacology, Risks & Safety Information

2-Methyl-AP-237 is a synthetic opioid and a member of the cinnamylpiperazine group of novel psychoactive substances. This compound has been studied by researchers for its activity at the µ-opioid receptor, the same receptor system at which established opioid drugs act. However, 2-Methyl-AP237 does not have an approved medical use and has been associated with serious toxicological concerns.

What is ap-237 2-methyl?

2-Methyl-AP-237 is also known by the names 2-methyl AP237, Methyl-AP237, and 2-MAP. In PubChem the molecular formula is listed as C18H26N2O and the molecular weight is listed as approximately 286.4 g/mol. CAS number 98608-61-8 (free compound) Identification of related salt is also reported in regulatory documents.

It is chemically related to the acyl piperazine/cinnamylpiperazine family. Structurally, it’s different from fentanyl and the other classes of opioids, with a piperazine core and a cinnamyl group.

Chemicals Information

• Name: 2-Methyl-AP-237
• Synonyms 2-MAP Methyl-AP-237
• Molecular Formula C18H26N2O
• Molecular weight: about 286.4 g/mol.
• CAS: 98608-61-8
• Substance group: Piperazines
• Effect group Synthetics opioids
• IUPAC name: 1-[2-Methyl-4-(3-phenyl-2-propen-1-yl)piperazin-1-yl]butan-1-one

How does 2-Methyl-AP-237 operate?

2-Methyl-AP-237 has been shown in studies to be a µ-opioid receptor agonist. These receptors are important in the perception of pain, reward, sedation, and respiratory control. As such, 2-Methyl-AP237 has been studied in the laboratory as a non-fentanyl synthetic opioid.

Additionally, laboratory studies have demonstrated opioid receptor activity that differentiates it from regular research chemicals which do not have opioid activity. Lab potency measurements, however, do not give a safe human dose and should not be used to determine personal use. Information on the human pharmacokinetics is still limited.

Research Results

2-Methyl-AP-237 has been studied in receptor assays and toxicological samples. One study found measurable µ-opioid receptor activation; another government review said its activity was less than fentanyl in the laboratory systems tested.

Researchers have also identified 2-Methyl-AP-237 in postmortem toxicology cases which is significant. Its presence in forensic investigations has therefore raised concerns about its possible toxic effects.

Possible health effects

Opioid-like side effects may occur, as 2-Methyl-AP237 acts on µ-opioid receptors. These can include sedation and respiratory depression. Severe intoxication can be life threatening. Regulatory agencies have also linked the abuse of the drug to deaths.

Repeated use of opioids can also result in the development of tolerance and dependence. There is little evidence specific to 2-Methyl-AP237, but expert reviews have highlighted concerns about dependence and withdrawal based on its pharmacology and reported patterns of use.

Why is it High Risk? (continued)

The combination of opioid receptor activity, limited safety data in humans, uncertain product composition, and reports of serious intoxication are the main concerns. Thus, novel synthetic opioids are a prominent public-health concern for researchers and regulators.

Legal/Regulatory Environment

The legal status of 2-Methyl-AP237 varies country to country and can change over time. It belongs to the group of synthetic opioid substances according to the United Nations catalogue and was internationally scheduled in 2023.

So anyone researching or dealing with this substance should look up the current regulations applicable in their country and not rely on an old classification.

2-Methyl-AP-237 for research use

Researchers interested in opioid receptor pharmacology, toxicology, analytical detection and new trends in synthetic opioids may study such compounds as 2-Methyl-AP237. Such research can help labs identify unknown substances and better understand public-health risks related to opioids.

But, research information is not to be taken as support that the compound is safe for human consumption. There are insufficient clinical data available to define an approved therapeutic role for 2-methyl-AP237.

Summary

2-Methyl-AP-237 is a synthetic opioid belonging to the class of cinnamylpiperazines. Scientific studies show activity at the µ-opioid receptor, while forensic and regulatory data raise serious safety concerns. As there is still little information available on human safety and pharmacokinetics, this compound should be considered as a high-risk substance and handled under all lab, legal, and safety requirements.